louisiana semaglutide intestinal paralysis class action Novo Nordisk is suing Eli Lilly over its GLP-1 ads, accusing the rival drugmaker of false advertising for claiming Lilly's Mounjaro and Zepbound outperform Novo's Ozempic and Wegovy. MORE BELOW ⬇️ glp-1 digestive blockage class action

This readily denotes that over 100 million adults are impacted by this disease, and more than 22 million suffer from severe obesity

Actual weight loss typically begins around weeks two through four, accelerates during months two through six, and then gradually plateaus around months ten through twelve

Hernias may remain asymptomatic or can progress over time from being reduceable to incarcerated where tissue becomes trapped in the hernia sac or even strangulated where blood flow is cut off

GPX1 KO mice developed normally, indicating that the lack of antioxidant defenses could be compensated for by other proteins, or that oxidative stress under normal conditions did not cause any harm